Veradermics (MANE) Prepaid Assets (2024 - 2026)
Veradermics (MANE) reported Prepaid Assets of $602000.0 for Q1 2026, up 96.09% quarter-over-quarter from $307000.0 in Q4 2025.
Veradermics (MANE) Prepaid Assets (2024 - 2026) Analysis & Trends
Veradermics has reported Prepaid Assets for 3 years, with the latest figure at $602000.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets changed N/A year-over-year to $602000.0; the trailing twelve-month figure through Mar 2026 stood at $602000.0 (changed N/A YoY), and the FY2025 full-year result was $307000.0, up 707.89% from the prior year.
- Prepaid Assets for Q1 2026 stood at $602000.0, up from $307000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $602000.0 in Q1 2026, with the low at $38000.0 in Q4 2024.
- Historically, Prepaid Assets has averaged $315666.7 across 3 years, with a median of $307000.0 in 2025.
- The largest YoY upside for Prepaid Assets was 707.89% in 2025 against a maximum downside of 707.89% in 2025.
- Veradermics' Prepaid Assets stood at $38000.0 in 2024, then soared by 707.89% to $307000.0 in 2025, then surged by 96.09% to $602000.0 in 2026.
- The last three Prepaid Assets figures came in at $602000.0 (Q1 2026), $307000.0 (Q4 2025), and $38000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Veradermics | 2.13 Bn | 2.13 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 602,000.00 |
| Dec 31, 2025 | 307,000.00 |
| Dec 31, 2024 | 38,000.00 |